By using a panel of previously well-characterized cancer-associated pathway reporter analyses [25, 29–31], we found at least four pathways, e.g., ELK1/SRF, AP1, STAT1/2, MYC/MAX, are significantly affected. The gene discussed is STAT1; the disease is cancer.